Turning Barriers Into Bridges: Health Plan Strategies to Support the HCV Care Cascade
Thursday, November 2, 2023 at 2-3 PM ET Pricing: Free for Members and Non-Members
Please note that this session is not accredited for continuing pharmacy education credit.
This expert-led webinar will explore the state of HCV in the United States, testing and treatment recommendations, key barriers to HCV treatment access and their impacts, how payers benefit from expanding HCV treatment access, treatment considerations for today's complex HCV population, and a treatment option that addresses many of the needs of today's patient population.
Nearly a decade after the development of direct-acting antiviral treatments that can cure HCV in more than 95% of people infected, only a small fraction of the 2.5 million people with chronic HCV in the United States have received treatment, and tens of thousands still die from the disease every year. This expert-led webinar will highlight:
- How many people in the United States have HCV and what percentage are diagnosed and treated
- Which patients are currently most likely to be infected with HCV
- HCV screening and treatment recommendations from major medical organizations
- Major barriers to HCV treatment and which patients are most impacted by them
- Benefits for payers of expanding HCV treatment access
- Important treatment considerations for today's complex chronic HCV patient population, including common comorbidities, concomitant medications, and lifestyle factors
- A treatment option for HCV that addresses many of the needs of today's patient population
The objectives of this presentation are to:
- Illustrate the burden of HCV in the United States and key barriers to HCV treatment access
- Present data on the potential cost savings generated by treating HCV
- Highlight important treatment considerations for today's complex HCV patient population and present information about a treatment option for chronic HCV and how it addresses the needs of today's patient population
This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenters are those of the sponsor or presenters and not of AMCP.
For individuals from the media/press interested in attending, please email email@example.com.
Estay Greene, PharmD, MBA
Managed Care Executive
Carrie Frenette, MD
Executive Director Medical Affairs
Gilead Sciences, Inc